ASRS
VRDN icon

Arizona State Retirement System’s Viridian Therapeutics VRDN Stock Holding History

Arizona State Retirement System’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Buy
21,330
+3,431
+19% +$55.3K ﹤0.01% 1649
2026
Q1 		$350K Sell
17,899
-425
-2% -$12.6K ﹤0.01% 1656
2025
Q4 		$570K Buy
18,324
+1,460
+9% +$40K ﹤0.01% 1404
2025
Q3 		$364K Buy
16,864
+229
+1% +$4.13K ﹤0.01% 1685
2025
Q2 		$233K Buy
16,635
+719
+5% +$9.76K ﹤0.01% 1844
2025
Q1 		$215K Sell
15,916
-680
-4% -$11.6K ﹤0.01% 1859
2024
Q4 		$318K Buy
16,596
+2,708
+19% +$58.9K ﹤0.01% 1722
2024
Q3 		$316K Buy
13,888
+710
+5% +$11.6K ﹤0.01% 1737
2024
Q2 		$171K Buy
13,178
+1,688
+15% +$23.4K ﹤0.01% 1937
2024
Q1 		$201K Buy
11,490
+1,957
+21% +$37.9K ﹤0.01% 1925
2023
Q4 		$208K Buy
+9,533
New +$150K ﹤0.01% 1936
2023
Q2 		– Sell
-8,746
Closed -$222K – 2237
2023
Q1 		$222K Buy
8,746
+303
+4% +$9.71K ﹤0.01% 1879
2022
Q4 		$247K Buy
+8,443
New +$195K ﹤0.01% 1793

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arizona State Retirement System's VRDN Position: Q2 2026 in Review

Arizona State Retirement System increased its Viridian Therapeutics (VRDN) stake by 19% in Q2 2026, buying an estimated $55.3K and bringing the position to 21,330 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

Arizona State Retirement System first reported a position in VRDN in Q4 2022 and has held it in 13 quarters since. The position peaked at $570K in Q4 2025. 215 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • Arizona State Retirement System held 21,330 shares of Viridian Therapeutics worth $392K as of Q2 2026.
  • Arizona State Retirement System bought 3,431 Viridian Therapeutics shares in Q2 2026, an estimated $55.3K.
  • Viridian Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1649 holding.
  • Arizona State Retirement System first reported a position in Viridian Therapeutics in Q4 2022 and has held it in 13 quarters since.
  • Arizona State Retirement System's Viridian Therapeutics position peaked at $570K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.